Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Janis K. Fraser, Ph.D.

Principal

Boston, MA
617-521-7037
fraser@fr.com
Download vCard
Janis K. Fraser, Ph.D. Photo

Background

Janis K. Fraser is a scientist-turned-lawyer who specializes in finding practical solutions to the most challenging patent issues that frequently accompany complex biotechnology and pharmaceutical inventions. A Principal in the Boston office of Fish & Richardson, Dr. Fraser has been providing strategic patent advice for over 25 years to clients ranging from startup biotech companies to multinational pharmaceutical corporations to academic institutions. She has assisted clients in obtaining patents claiming inventions such as antibodies, gene therapies, recombinant proteins, transgenic animals, pharmaceutical compounds and formulations, cosmetics, methods of treatment, and diagnostic methods. Dr. Fraser has a particular interest in patent issues surrounding personalized medicine. Her expertise extends to due diligence studies and opinions regarding validity and infringement issues.

Dr. Fraser was recognized as a “Life Science Star” by LMG Life Sciences (2012-2017), where clients are quoted as describing her as “creative, open minded, attentive to detail,” an “expert at managing difficult prosecution and opinion related issues,” and someone who possesses a “strong work ethic, and encyclopedic understanding of every facet of U.S. patent law” and is “always in possession of a creative solution.”

Education

J.D., Harvard Law School 1985


Ph.D., Massachusetts Institute of Technology 1976
Biochemistry


B.S., Nebraska Wesleyan University 1971
Chemistry
with highest distinction

Admissions

  • U.S. Patent and Trademark Office 1991
  • Massachusetts 1985

Memberships & Affiliations

​Member of the Editorial Board for Life Sciences Intellectual Property Review.

Member of the Advisory Board for MIT's David H. Koch Institute for Integrative Cancer Research.

Other Distinctions

Named to “The Best Lawyers in America” list in Patent Law by The Best Lawyers in America© (2018-2019).

Named to “Best Lawyers in New England” by The Wall Street Journal (2018).

Named an “IP Star” by Managing Intellectual Property magazine (2014-2018).

Recognized in “IAM Patent 1000 – The World’s Leading Patent Professionals” (2016-2018).

Named a “Life Science Star” by LMG Life Sciences (2012-2017).

Recognized as a “World’s Leading Life Sciences Lawyer” by Who’s Who Legal (2016).

Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation” (2015-present).

Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman, and Litigation” (2000-2014).

Author of articles including:

An End-Run Around Myriad And ‘Product Of Nature’ Problem,” Law360 (September 2016) (co-authored with Sarah M. Cork).

Bulletproofing Pharma Patents,” LSIPR Newsletter (December 2014) (co-authored with Christine Goddard).

“Patenting Genes in a Post-Myriad World,” Industrial Biotechnology (August 2013) (co-authored with Michael Rosen).

Myriad: Picking Up the Pieces,” LSIPR Newsletter (June 2013).

Making Follow-On Biologics a Reality,” Genetic Engineering & Biotechnology News 31:8-10 (2011) (co-authored with Graham B. Jones).

U.S. Gene Patents in Legal Limbo—for Now,” Genetic Engineering & Biotechnology News 28:10 (2008).

Ph.D. thesis entitled “In Vitro HeLa DNA Synthesis: Investigation of the Nature of Replication and a Stimulatory Factor from HeLa Cells.”

What's trending with Janis

Filter by
News
August 15, 2018
46 Fish Attorneys Named to The Best Lawyers in America® 2019 List
Articles
News
June 14, 2018
Fish Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
News
May 21, 2018
Fish & Richardson Announces 39 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
Press Release
Event
April 15th, 2018 | 8:15 am CDT
Patent Resources Group (PRG) Spring 2018 Advanced Courses Program
Patent Resources Group (PRG) Spring 2018 Advanced Courses Program
Speaking Engagement
News
October 13, 2017
11 Fish & Richardson Principals Named 2017 "Life Sciences Stars" by LMG Life Sciences
Press Release
News
August 22, 2017
Fish & Richardson Announces Four Principals Named 2017 “Women Worth Watching” by Profiles in Diversity Journal
Press Release
News
July 24, 2017
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
Event
April 16th, 2015 | 8:00 am EDT
Patent Resources Group (PRG) Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
Speaking Engagement
Event
April 16th, 2015
Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
Speaking Engagement
Event
March 30th, 2014
Patent Resources Group PRG course: Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman and Litigation
Event
September 11th, 2013
Claiming Biological Inventions Post-Myriad: A "Myriad" of Strategies
Speaking Engagement
Event
April 15th, 2010 | 8:00 am EDT
Patent Resources Group class "Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman and Litigation"
Speaking Engagement
load more topics